Focusing on Quality for Parenteral Drug Manufacturing

News
Article

Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected


      Susan Schniepp, vice-president of quality and regulatory affairs at Allergy Laboratories and co-chair of the program planning committee for the 2013 PDA/FDA Joint Regulatory Conference, discusses quality systems and related considerations in parenteral drug manufacturing.

      Newsletter

      Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

      Subscribe Now!
      Recent Videos
      Behind the Headlines, Episode 18
      Behind the Headlines, Episode 18: Sanofi, GSK Go Big in M&A, mRNA Momentum Falters, and More
      Drug Digest: Patient Preference Drives Solid Dosage Trends
      Drug Digest: Patient Preference Drives Solid Dosage Trends
      Behind the Headlines, Episode 17
      Behind the Headlines, Episode 17: Bespoke CRISPR Therapy, Executive Order Fallout, and More
      Industry Outlook 2025: European Political Impacts on the Supply Chain
      Industry Outlook 2025: European Political Impacts on the Supply Chain
      AAPS National Biotechnology Conference 2025: High-Concentration Biologics
      AAPS National Biotechnology Conference 2025: High-Concentration Biologics
      Industry Outlook 2025: The Future of Technology in the Biopharma Industry
      Industry Outlook 2025: The Future of Technology in the Biopharma Industry
      AAPS National Biotechnology Conference 2025: AAV Vector Production
      AAPS National Biotechnology Conference 2025: AAV Vector Production
      Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
      Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
      Industry Outlook 2025: Technology as a Supporting Element
      Industry Outlook 2025: Technology as a Supporting Element
      Industry Outlook 2025: Talent Up for Grabs
      Industry Outlook 2025: Talent Up for Grabs
      Related Content
      Young man having asthma attack or choking suffering from respiration problems | Image Credit: © Feodora - stock.adobe.com

      UK Anaphylaxis Nasal Spray Approval Helps Reshape Emergency Allergy Treatment

      Christopher Cole
      July 18th 2025
      Article

      Newly approved needle-free adrenaline spray offers longer shelf life, better stability, and easier use, signaling a shift in emergency drug delivery design.

      Drug Solutions Podcast: Growth and Advancements in Fill/Finish

      Drug Solutions Podcast: Growth and Advancements in Fill/Finish

      Felicity Thomas
      June 25th 2024
      Podcast

      In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

      Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

      EMA Moves to Secure Supply of Critical Drugs Used During Pregnancy

      Susan Haigney
      July 10th 2025
      Article

      The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.

      Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

      Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

      Feliza Mirasol
      April 30th 2024
      Podcast

      In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

      medicine and vision concept - woman closeup and eye diagram, future technologies | Image Credit: ©Julia - stock.adobe.com

      Advanced Solutions for Sustained Delivery of Ocular Therapies

      Cynthia A. Challener
      July 4th 2025
      Article

      Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.

      Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

      Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

      Susan Haigney
      July 2nd 2025
      Article

      The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.